Lipella Pharmaceuticals News - LIPO

Company Name	Stock Ticker Symbol	Market	Type
Lipella Pharmaceuticals Inc	LIPO	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.0046	0.64%	0.7179	19:43:30

Open Price	Low Price	High Price	Close Price	Prev Close
0.72375	0.704	0.7238	0.7179	0.7133

more quote information »

Recent News

Date	Time	Source	Heading
4/17/2024	08:00	GLOBE	Lipella Pharmaceuticals Expands its Advisory Board to..
4/05/2024	08:00	GLOBE	Lipella Pharmaceuticals to Publish Abstract Detailing..
4/03/2024	08:00	GLOBE	Lipella Pharmaceuticals Announces FDA Type C Meeting for..
3/07/2024	15:23	GLOBE	PRISM MarketView Spotlights Lipella Pharmaceuticals as it..
3/06/2024	17:05	EDGAR2	Form SC 13D/A - General statement of acquisition of..
3/06/2024	17:03	EDGAR2	Form SC 13D/A - General statement of acquisition of..
3/05/2024	08:00	GLOBE	Lipella Pharmaceuticals Announces FDA Clearance of IND for..
2/27/2024	17:04	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
2/27/2024	16:51	EDGAR2	Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2/20/2024	08:00	GLOBE	Lipella Pharmaceuticals to Present at PropThink Digital..
2/09/2024	00:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2/07/2024	17:29	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/01/2024	16:09	EDGAR2	Form S-3 - Registration statement under Securities Act of..
1/25/2024	16:06	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
1/03/2024	16:59	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
12/20/2023	08:00	GLOBE	Lipella Pharmaceuticals Marks Successful First Year with..
11/28/2023	17:28	EDGAR2	Form 8-K - Current report
11/22/2023	16:05	EDGAR2	Form 8-K - Current report
11/14/2023	06:22	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/14/2023	06:14	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/10/2023	08:00	PRNUS	FDA Grants Orphan Designation for Lipella's LP-310 Drug..
11/09/2023	16:07	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
11/01/2023	16:06	EDGAR2	Form S-1 - General form for registration of securities under..
10/25/2023	16:05	PRNUS	Lipella Pharmaceuticals Announces Closing of $2 Million..
10/24/2023	08:00	PRNUS	Lipella Pharmaceuticals Announces $2 Million Private..
10/20/2023	08:00	PRNUS	Lipella Pharmaceuticals Announces FDA Clearance of IND for..
10/10/2023	16:05	EDGAR2	Form DEF 14A - Other definitive proxy statements
9/21/2023	08:30	PRNUS	Lipella Pharmaceuticals' Phase 2a Clinical Study Results..
9/11/2023	07:38	EDGAR2	Form 8-K - Current report
8/14/2023	16:16	EDGAR2	Form 424B3 - Prospectus [Rule 424(b)(3)]
8/14/2023	16:04	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/08/2023	16:30	EDGAR2	Form 8-K - Current report
8/02/2023	16:05	EDGAR2	Form 8-K - Current report
5/15/2023	09:17	PRNUS	Lipella Pharmaceuticals Reports First Quarter 2023 Financial..
5/01/2023	08:30	PRNUS	Lipella Pharmaceuticals Delivers Late-Breaking Presentation..